TP53 and cancer: It is unlikely that the apoptotic fraction will contribute to secondary cancer induction (except possibly in TP53 mutant cell lines), so it is useful that this fraction can be estimated using the new RHR formula and removed from other forms of misrepair to more accurately describe the cells that are potentially capable of generating secondary cancer.